JOHNSON & JOHNSON’S Q2 PROFITS RISE 73%

Johnson & Johnson’s second- quarter profit soared 73%, thanks to strong sales growth as the health care industry continued recovering from the pandemic’s impact. The health care giant topped Wall Street expectations and hiked its 2021 sales and profit forecasts. The world’s biggest maker of health care products on Wednesday reported second- quarter net income of $ 6.28 billion, or $ 2.35 per share, up from $ 3.63 billion, or $ 1.36 per share, a year earlier. Adjusted income came to $ 6.63 billion, or $ 2.48 per share.

RICHARD DREW/ AP